Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection

Yuan Ju,Qi An,Yiwen Zhang,Ke Sun,Lang Bai,Youfu Luo
DOI: https://doi.org/10.1016/j.drudis.2021.05.014
IF: 8.369
2021-09-01
Drug Discovery Today
Abstract:<p>The caseinolytic protease (ClpP) is an AAA<sup>+</sup> protease that executes abnormally folded or malfunctioning proteins, and has an important role in producing virulence factors, forming biofilms or persisters and developing methicillin-resistant <em>Staphylococcus aureus</em> (MRSA). Recent studies showed that ClpP controls virulence via <em>agr</em> signaling and degrades antitoxins of the toxin–antitoxin system to modulate the formation of persisters and biofilms. In this review, we focus on recent developments concerning the virulence and persistence regulatory pathways and resistance-related mechanism of ClpP in <em>S. aureus</em>, with an overview of the Clp modulators developed to treat MRSA infection.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?